Search Legislation

The Misuse of Drugs (Amendment) (No. 3) Regulations (Northern Ireland) 2006

What Version

 Help about what version
  • Latest available (Revised)
  • Original (As made)

Opening Options

 Help about opening options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of the Misuse of Drugs Regulations 2002

7.—(1) In regulation 16(1), before “A person”, insert “subject to paragraph (5),”.

(2) In regulation 16(1)(a), before “unless”, insert “subject to paragraphs (1A) and 1C),”.

(3) In regulation 16(1)(d), (e) and 3(a) for “date specified in the prescription” substitute “appropriate date”.

(4) In regulation 16(1)(e) and 3(a), for “thirteen weeks” substitute “twenty-eight days”.

(5) After regulation 16(1), insert—

(1A) A pharmacist may supply a controlled drug other than a drug specified in Schedule 4 or 5 or temazepam if the prescription contains minor typographical errors or spelling mistakes or if it does not comply with the provisions of regulation 15 in the way specified in paragraph (1B), provided that—

(a)having exercised all due diligence, he is satisfied on reasonable grounds that the prescription is genuine;

(b)having exercised all due diligence, he is satisfied on reasonable grounds that he is supplying the drug in accordance with the intention of the person issuing the prescription;

(c)he amends the prescription in ink or otherwise indelibly to correct the minor typographical errors or spelling mistakes or so that the prescription complies with the requirements of regulation 15 as the case may be; and

(d)he marks the prescription so that the amendment he has made under sub-paragraph (c) is attributable to him.

(1B) The way specified in paragraph (1A) is that, in relation to regulation 15(1)(f), the total quantity of the preparation or of the controlled drug or the number of dosage units as the case may be is specified in either words or figures but not both.

(1C) A pharmacist may supply a controlled drug other than a drug specified in Schedule 4 or 5 on a prescription other than a health prescription in a hospital if it does not comply with regulation 15 in the ways specified in paragraph (1D).

(1D) The ways specified in paragraph (1C) are—

(a)the prescription is not written on a prescription form provided by a Primary Care Trust or equivalent body for the purposes of private prescribing;

(b)the prescription does not specify the prescriber identification number of the person issuing it.

(6) After regulation 16(3), insert—

(4) A person shall not supply a controlled drug specified in Schedule 4 on a prescription, later than twenty-eight days after the appropriate date.

(5) A person who is asked to supply on prescription a controlled drug specified in Schedule 2 must first ascertain whether the person collecting the drug is the patient, the patient’s representative or a health care professional acting in his professional capacity on behalf of the patient; and—

(a)where the person is the patient or the patient’s representative, he may—

(i)request evidence of that person’s identity; and

(ii)refuse to supply the drug if he is not satisfied as to the identity of that person;

(b)where that person is a health care professional acting in his professional capacity on behalf of the patient, he—

(i)must obtain that person’s name and address;

(ii)must, unless he is acquainted with that person, request evidence of that person’s identity; but

(iii)may supply the drug even if he is not satisfied as to the identity of that person.

(6) In this regulation—

“appropriate date” means the later of the date on which it was signed by the person issuing it or the date indicated by him as being the date before which it shall not be supplied;

“health care professional” has the same meaning as in Article 15C of the Health and Personal Social Services (Northern Ireland) Order 1972(1);

“patient” means the person named in the prescription as the person to whom the drug is to be supplied;

“patient’s representative” means a person sent by or on behalf of the patient (other than a health care representative acting in his professional capacity)..

(1)

Article 15C is inserted by Article 21 of the S.I. 1997/1177 (N.I. 7) and amended by Article 6 of S.I. 2004/311 (N.I. 2)

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources